← Leaderboards
Binhua Ling
Tulane University Of Louisiana
$11,108,146
Attributed
$15,561,856
Total exposure
20
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,561,856 · 20
By mechanism
R01$13,822,535 · 5
R56$841,702 · 1
P51$694,143 · 12
P20$203,476 · 2
Top collaborators
- Wenhui Hu5 shared
- Andrew G Maclean5 shared
- Jian Zhu1 shared
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Mahesh Mohan$12,801,428
- Angela M Amedee$2,356,313
- Elizabeth Schmidt Didier$8,050,961
- Joseph Christopher Mudd$5,625,443
- Ivona Pandrea$33,088,190
Others in their field
Top investigators on “Macaca Mulatta”
- Barton F Haynes · Duke University$291,595,855
- Peter Gordon Gillespie · Oregon Health And Science University$83,402,374
- Richard A Gibbs · Baylor College Of Medicine$82,928,769
- Dan H. Barouch · Fred Hutchinson Cancer Center$67,567,747
- David I Watkins · George Washington University$57,087,952
- Rama Rao Amara · Emory University$54,145,017
Research focus
Macaca MulattaInfectionMacacaCellsChinese PeopleSourceVirusHiv-1AnimalsViralAntiretroviral TherapyT-LymphocyteHiv InfectionsPlasmaTissuesNonhuman PrimateGenesRegimenResearch PersonnelBrainIn VivoMacrophageNeuroaidsMicroglia
Grant awards (33)
Targeted CRISPR/Cas Editing to Eliminate SIV CNS Reservoir in Methamphetamine-Exposed Rhesus Macaques on ART$1,144,344
R01 · FY2025 · DA · contact PI
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication$771,175
R01 · FY2025 · MH · contact PI
Antagonize Host Survival and Immune Escape Mechanisms for Elimination of HIV Viral Reservoirs$841,702
R56 · FY2024 · AI
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication$786,365
R01 · FY2024 · MH · contact PI
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication$795,229
R01 · FY2023 · MH · contact PI
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication$915,398
R01 · FY2022 · MH · contact PI
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound$698,657
R01 · FY2022 · MH · contact PI
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound$708,641
R01 · FY2021 · MH · contact PI
Eradication of latent SIV from the CNS$672,433
R01 · FY2021 · NS
Eradication of latent SIV from the CNS$804,637
R01 · FY2020 · NS
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound$645,675
R01 · FY2020 · MH · contact PI
Eradication of latent SIV from the CNS$813,133
R01 · FY2019 · NS
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound$645,675
R01 · FY2019 · MH · contact PI
Eradication of latent SIV from the CNS$787,475
R01 · FY2018 · NS
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound$662,689
R01 · FY2018 · MH · contact PI
Eradication of latent SIV from the CNS$575,530
R01 · FY2017 · NS
Identification and eradication of HIV tissue reservoirs in a relevant animal mode$752,478
R01 · FY2013 · AI · contact PI
Identification and eradication of HIV tissue reservoirs in a relevant animal mode$812,757
R01 · FY2012 · AI · contact PI
Identification and eradication of HIV tissue reservoirs in a relevant animal mode$830,244
R01 · FY2011 · AI · contact PI
ROLE OF NK CELLS IN SIV-INFECTED LONG-TERM NONPROGRESSING RHESUS MACAQUES$57,750
P51 · FY2011 · RR · contact PI
TISSUE RESERVOIRS IN SIV-INFECTED LONG TERM NONPROGRESSORS$57,750
P51 · FY2011 · RR · contact PI
ROLE OF NK CELLS IN SIV-INFECTED LONG-TERM NONPROGRESSING RHESUS MACAQUES$61,801
P51 · FY2010 · RR · contact PI
RESERVOIRS IN THE INTESTINAL MUCOSA IN SIV-INFECTED LONG TERM NONPROGRESSORS$61,801
P51 · FY2010 · RR · contact PI
IMMUNE RESTORATION AND PROTECTION IN SIV-INFECTED LONG TERM NONPROGRESSORS$104,992
P20 · FY2009 · RR · contact PI
IMMUNE RESTORATION AND PROTECTION IN SIV-INFECTED LONG TERM NONPROGRESSORS$60,376
P51 · FY2009 · RR · contact PI
NK CELLS IN SIV-INFECTED LONG-TERM NONPROGRESSING RHESUS MACAQUES$60,376
P51 · FY2009 · RR · contact PI
IMMUNE RESTORATION AND PROTECTION IN SIV-INFECTED LONG TERM NONPROGRESSORS$98,484
P20 · FY2008 · RR · contact PI
LONGITUDINAL FOLLOW UP OF SIVMAC PATHOGENESIS IN MACAQUES OF CHINESE ORIGIN$64,630
P51 · FY2008 · RR · contact PI
IMMUNE RESTORATION AND PROTECTION IN SIV-INFECTED LONG TERM NONPROGRESSORS$64,630
P51 · FY2008 · RR · contact PI
RESERVOIRS OF SIV IN LONG TERM NONPROGRESSORS IN RHESUS MACAQUES$71,639
P51 · FY2007 · RR · contact PI
LONGITUDINAL FOLLOW UP OF SIVMAC PATHOGENESIS IN MACAQUES OF CHINESE ORIGIN$71,638
P51 · FY2007 · RR · contact PI
RHESUS MACAQUE MODEL FOR GBV-C AND SIV CO-INFECTION$32,906
P51 · FY2007 · RR · contact PI
RHESUS MACAQUE MODEL FOR GBV-C AND SIV CO-INFECTION$28,846
P51 · FY2006 · RR · contact PI